Back to search

National and Kapodistrian University of Athens

Δράση των αναστολέων των απακετυλασών των ιστονών (HDACI) στον καρκίνο του μαστού

Abstract

dc:description

Introduction: Breast cancer - which is known to human from ancient times - is the most commonly diagnosed cancer in women. It is the second leading cause of death from malignancy after lung cancer in developed countries, despite advances in both diagnosis and treatment. This is the reason why research is oriented towards new strategies, while the knowledge of the molecular background and the mechanisms involved is expected to be the basis for the development of new, more effective treatments. In this context, it has been found that dysfunctions in the equilibrium of acetylation and deacetylation of histones by acetyltransferases (HAT) and histone deacetylases (HDAC) respectively, participate in the occurrence of malignancies. In fact, over-expression of HDAC has been detected in a variety of cancers while their inhibitors (Histone deacetylase inhibitors, HDACI) are already used in clinical practice to treat mainly hematological malignancies. However, in the case of breast cancer, the data remain incomplete. Aim: The aim of the present study is to evaluate the immunohistochemical expression of HDAC-2 in breast cancer and to highlight its targeting as a future anti-cancer treatment strategy. Material and Methods: Sample tissues from breast cancer patients were evaluated immunohistochemically for HDAC-2 expression and its association with clinicopathological parameters of the patients. Results: A strong HDAC-2 expression was associated with lobular cancer type, grade III and stage III. In addition, HDAC-2 over-expression was associated with reduced survival. Finally, a significant correlation was found between the increased expression of HDAC-2 and the negative expression of C-erb B-2. Conclusions: The aforementioned results of this study pave the way for new therapeutic strategies. Further studies are needed to highlight HDACI as a new class of targeted therapy for breast cancer.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Garmpis, Nikolaos
  • Γαρμπής, Νικόλαος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47581

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Garmpis, Nikolaos; Γαρμπής, Νικόλαος. Δράση των αναστολέων των απακετυλασών των ιστονών (HDACI) στον καρκίνο του μαστού. National and Kapodistrian University of Athens, 2020. http://hdl.handle.net/10442/hedi/47581